中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Endogenous contrast t1rho cardiac magnetic resonance for myocardial fibrosis in hypertrophic cardiomyopathy patients

文献类型:期刊论文

作者Wang, Chunhua1; Zheng, Jie2; Sun, Jiayu1; Wang, Yuqing1,3; Xia, Rui1,4; Yin, Qian2; Chen, Wei1; Xu, Zigian1; Liao, Jichun1,4; Zhang, Bing1
刊名Journal of cardiology
出版日期2015-11-01
卷号66期号:5-6页码:520-526
关键词Hypertrophic cardiomyopathy Cardiac magnetic resonance T1rho Endogenous contrast Myocardial fibrosis
ISSN号0914-5087
DOI10.1016/j.jjcc.2015.03.005
通讯作者Gao, fabao(gaofabao@yahoo.com)
英文摘要Background: late gadolinium enhancement (lge) is a standard method to evaluate myocardial fibrosis, but restricted due to contrast agent contraindications. non-contrast t1rho can generate endogenous contrast, and detect fibrosis in chronic myocardial infarction. however, t1rho for hypertrophic cardiomyopathy (hcm) patients is still unreported. the present study aimed to investigate t1rho for fibrotic assessment and the clinical implication in hcm patients. methods: 18 hcm patients and 8 controls underwent t1rho, cine, and lge cardiac magnetic resonance (cmr). t1rho relaxation time maps were created. left ventricular (lv) parameters assessed included wall thickness, wall thickening, chamber volumes, ejection function, and fibrotic size. new york heart association (nyha) functional classification was conducted. results: hyper-t1rho value was identified in 12 hcm patients, consistent with lge. the mean t1rho values of controls, lge-negative patients, and remote myocardium of lge-positive patients were 42.2 +/- 1.6 ms, 43.9 +/- 2.5 ms, and 42.5 +/- 1.2 ms respectively, and these values showed no significant difference (all p > 0.05). tlrho-3-sd and tlrho-4-sd fibrotic sizes (32.5 +/- 14.0% and 25.1 +/- 11.5%) did not differ from lge fibrotic size (28.1 +/- 11.2%) (both p > 0.05). for the fibrotic size, tlrho-3-sd method obtained the strongest correlation with lge (r = 0.88, p < 0.001), and t1rho-4-sd obtained the minimal mean difference with lge (-3.1%; 15.2 to 9.1%), compared with other sds. all the fibrotic sizes assessed by both methods correlated directly with lv maximal end-diastolic thickness (all p <0.05). negative correlation was found between t1rho-4-sd fibrotic size and lv ejection fraction (r = 0.49, p = 0.11). t1rho-4-sd fibrotic size showed positive correlation with nyha class (r = 0.46, p = 0.13). conclusions: t1rho cmr has potential to detect fibrosis in hcm patients. 4-sd may be the appropriate threshold for assessment. (c) 2015 japanese college of cardiology. published by elsevier ltd. all rights reserved.
WOS关键词LATE GADOLINIUM ENHANCEMENT ; IN-VIVO ; CLINICAL-SIGNIFICANCE ; DELAYED ENHANCEMENT ; DIASTOLIC FUNCTION ; RELAXATION ; INFARCTION ; TIME ; DEGENERATION ; DEATH
WOS研究方向Cardiovascular System & Cardiology
WOS类目Cardiac & Cardiovascular Systems
语种英语
WOS记录号WOS:000366868600024
出版者ELSEVIER SCIENCE BV
URI标识http://www.irgrid.ac.cn/handle/1471x/2176430
专题高能物理研究所
通讯作者Gao, Fabao
作者单位1.Sichuan Univ, Dept Radiol, West China Hosp, Chengdu 610064, Peoples R China
2.Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO USA
3.Natl Ctr Nanosci & Technol China, CAS Key Lab Biomed Effects Nanomat & Nanosafety, Beijing, Peoples R China
4.Chongqing Med Univ, Dept Radiol, Affiliated Hosp 1, Chongqing, Peoples R China
推荐引用方式
GB/T 7714
Wang, Chunhua,Zheng, Jie,Sun, Jiayu,et al. Endogenous contrast t1rho cardiac magnetic resonance for myocardial fibrosis in hypertrophic cardiomyopathy patients[J]. Journal of cardiology,2015,66(5-6):520-526.
APA Wang, Chunhua.,Zheng, Jie.,Sun, Jiayu.,Wang, Yuqing.,Xia, Rui.,...&Gao, Fabao.(2015).Endogenous contrast t1rho cardiac magnetic resonance for myocardial fibrosis in hypertrophic cardiomyopathy patients.Journal of cardiology,66(5-6),520-526.
MLA Wang, Chunhua,et al."Endogenous contrast t1rho cardiac magnetic resonance for myocardial fibrosis in hypertrophic cardiomyopathy patients".Journal of cardiology 66.5-6(2015):520-526.

入库方式: iSwitch采集

来源:高能物理研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。